Latigo Biotherapeutics, Inc.
Latigo’s corporate headquarters are in Thousand Oaks, California.
Latigo was incorporated in 2018.
Latigo is traded on the NASDAQ Global Market under the ticker symbol LTGO.
Latigo’s fiscal year ends on December 31.
PricewaterhouseCoopers LLP.
Cooley LLP.
Latigo’s press release archives can be viewed here.
Latigo’s SEC filings are available at investors.latigobio.com in the section SEC Filings and on the SEC’s website www.sec.gov.
You can submit queries to Latigo’s investor relations department by contacting ir@latigobio.com.
Equiniti Trust Company, LLC.